Email this article Tumors of Ewing family: treatment results of pediatric patients in Belarus Republic
- Authors: Kisialeu L.P.1
-
Affiliations:
- Republican Research Center for Pediatric Oncology, Hematology and Immunology, Minsk
- Issue: Vol 16, No 4 (2017)
- Pages: 43-50
- Section: Статьи
- Submitted: 09.08.2018
- Published: 09.11.2017
- URL: https://hemoncim.com/jour/article/view/7
- DOI: https://doi.org/10.24287/1726-1708-2017-16-4-43-50
- ID: 7
Cite item
Full Text
Abstract
Tumors of Ewing family (previously – Peripheral primitive neuroectodermal tumor) (TEF) arise in any bone or soft tissue and differs from the classical Ewing's sarcoma (ES) by markers of neuronal differentiation. The aim of the study was to investigate whether patient characteristics differ between cases with favorable and unfavorable outcomes. We also studied whether treatment strategies (for rhabdoid tumor or for classical ES) affects the clinical outcome of patients with TEF. 53 pediatric patients included in the Belarus Republic (RB) cancer registry database (involved in International Agency for Research on Cancer (IARC)) from 1999 to 2014 were evaluated. Survival rate was estimated via the Kaplan-Meier method and compared using logrank tests and Cox proportional hazard models. 15-year event-free survival (EFS) of all patients was 50.4%, for the cohorts of patients with localized and metastatic disease OS was 57.9 and 20.0% respectively. Known clinical characteristics (age, sex, tumors volume and other) did not differ between patients with localized TEF depending on the availability of favorable or unfavorable outcomes. Use of protocols for rhabdomyosarcoma associated with worse overall survival results (65% vs. 50%, n.s.) for localized TEF. Treatment results for patients with TEF of the Belarus Republic comply with generally accepted standards. Patients with metastatic status need new treatment strategies. Searching for new predictive markers is necessary for early detection of resistant to conventional treatment patients with localized TEF. For patients with localized TEF, who treated according to classical ES protocols, established an increasing number of favorable outcomes compared to curating according to the rhabdomyosarcomas chemotherapy schemes.
Keywords
About the authors
L. P. Kisialeu
Republican Research Center for Pediatric Oncology, Hematology and Immunology, Minsk
Author for correspondence.
Email: leonslight@mail.ru
ORCID iD: 0000-0003-2071-8143
M.D., Ph.D., сhief of the Department of Oncology and Hematology for Older Children
223053, Belarus, Minsk Region, v. Borovliany, Frunzenskaya, 43.
Tel.: +375 296 637833
Fax: +375 172 654222
References
Supplementary files
